Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Alba, Shire deal

Alba granted SHP exclusive rights to commercialize AT-1001 outside the U.S. and Japan. Alba

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE